One-Stop CLIA Solution with Open Systems and Resources Makes Evolution to Emerging World Healthcare Systems
Advanced, flexible cooperation models delivered by one-stop CLIA solution can boost government industrialization plans, laboratory technology updates, reagent R&D and localization, and even more investment flows to the industry
COVID-19 NAb Test CLIA Solution coupled with COVID-19 Ag Self Test to form a powerful stride for pandemic control
DONGGUAN, China, April 26, 2021 /PRNewswire/ -- Emerging markets such as Brazil, India and Russia are gradually adopting CLIA (Chemiluminescence Immunoassay) systems in recent years due to the high prevalence of chronic diseases. However, drawbacks like closed CLIA systems based on specific methodologies or reagent kits, deployment costs, long R&D time have hindered the industry transformation.

Related Keywords

China , Dongguan , Guizhou , India , Russia , Brazil , Kostenloser Wertpapierhandel , Fapon Biotech Inc , Self Test , Chemiluminescence Immunoassay , Fapon Biotech , One Stop Solution , Selt Test , Disease Identification Earlier , More Accurate , சீனா , இந்தியா , ரஷ்யா , பிரேசில் , சுய சோதனை , ஒன்று நிறுத்து தீர்வு , மேலும் திட்பநுட்பமான ,